晶体液量与儿童重型创伤性脑损伤短期并发症相关:东部创伤外科协会多中心试验事后分析
本文为东部创伤外科协会多中心前瞻性观察研究的事后分析,纳入2018—2019年现场转运、到达时儿童校正休克指数升高且头部简明损伤定级≥3的<18岁受伤儿童,比较sTBI与非sTBI患者的临床与复苏特征。sTBI患者初始血红蛋白更低(11.3 vs. 12.4,p<0.001)、初始国际标准化比值更高(1.4 vs. 1.1,p<0.001),接受更多院前晶体液(25% vs. 15%,p=0.008)、≥1次晶体液团注(52% vs. 24%,p<0.001)及输血(44% vs. 12%,p<0.001)。sTBI患者中接受≥1次晶体液团注者ICU需求更高(92% vs. 64%,p<0.001)、中位ICU时间更长(6 vs. 4天,p=0.027)、住院时间更长(9 vs. 4天,p<0.001)、院内并发症更多(31% vs. 7.5%,p=0.003),校正损伤严重度评分后仍存在(比值比3.4–4.4,所有p<0.010)。作者认为过量晶体液可能与sTBI患儿预后恶化相关,需进一步关注限制晶体液、早期输血的复苏方法。
要点
- sTBI患儿(n=142)较非sTBI患儿(n=547)接受更多院前晶体液(25% vs. 15%,p=0.008)和≥1次晶体液团注(52% vs. 24%,p<0.001)。
- sTBI患儿中接受≥1次晶体液团注者(n=75)ICU需求92% vs. 64%(p<0.001),中位ICU时间6 vs. 4天(p=0.027),住院时间9 vs. 4天(p<0.001)。
- sTBI患儿中接受≥1次晶体液团注者院内并发症31% vs. 7.5%(p=0.003),校正损伤严重度评分后比值比3.4–4.4(所有p<0.010)。
- sTBI患儿初始国际标准化比值更高(1.4 vs. 1.1,p<0.001)且输血更多(44% vs. 12%,p<0.001),但仍接受更多晶体液。
- 作者认为过量晶体液可能与sTBI患儿预后恶化(包括院内死亡)相关,需关注限制晶体液、早期输血的复苏方法。
适用人群与场景
- 2018—2019年现场转运的<18岁受伤儿童,到达时儿童校正休克指数升高且头部简明损伤定级评分≥3。
- 本研究比较sTBI患儿(n=142)与非sTBI患儿(n=547)。
诊断标准与关键阈值
- sTBI定义依据头部简明损伤定级评分≥3;入组还需到达时儿童校正休克指数升高。
- 晶体液团注次数以≥1次与<1次分组比较。
研究设计与关键结果
- 研究类型:东部创伤外科协会多中心前瞻性观察研究的事后分析;样本量:sTBI 142例,非sTBI 547例;人群:<18岁受伤儿童(2018—2019年),现场转运,到达时儿童校正休克指数升高且头部简明损伤定级≥3。
- sTBI vs. 非sTBI:初始血红蛋白11.3 vs. 12.4(p<0.001),初始国际标准化比值1.4 vs. 1.1(p<0.001),损伤严重度评分25 vs. 5(p<0.001)。
- sTBI vs. 非sTBI:机械通气率59% vs. 11%(p<0.001),ICU需求79% vs. 27%(p<0.001),院内并发症18% vs. 3.3%(p<0.001)。
- sTBI vs. 非sTBI:院前晶体液25% vs. 15%(p=0.008),≥1次晶体液团注52% vs. 24%(p<0.001),输血44% vs. 12%(p<0.001)。
- sTBI患者中,接受≥1次晶体液团注者(n=75)vs. <1次者(n=67):ICU需求92% vs. 64%(p<0.001),中位ICU时间6 vs. 4天(p=0.027),住院时间9 vs. 4天(p<0.001),院内并发症31% vs. 7.5%(p=0.003)。
- 校正损伤严重度评分后,上述关联持续存在:比值比3.4–4.4,所有p<0.010。
证据类型、等级与局限
- 证据类型:前瞻性观察研究的事后分析;证据等级:治疗/照护管理,Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- sTBI患儿接受≥1次晶体液团注与更高的ICU需求、更长的ICU及住院时间及更多院内并发症相关,校正损伤严重度评分后仍存在(比值比3.4–4.4,所有p<0.010)。
- 作者认为过量晶体液可能与sTBI患儿预后恶化(包括院内死亡)相关。
- 作者认为需进一步关注限制晶体液、早期输血的复苏方法用于sTBI患儿的复苏。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: This study examined differences in clinical and resuscitation characteristics between injured children with and without severe traumatic brain injury (sTBI) and aimed to identify resuscitation characteristics associated with improved outcomes following sTBI.
METHODS: This is a post hoc analysis of a prospective observational study of injured children younger than 18 years (2018-2019) transported from the scene, with elevated shock index pediatric-adjusted on arrival and head Abbreviated Injury Scale score of ≥3. Timing and volume of resuscitation products were assessed using χ 2t test, Fisher's exact t test, Kruskal-Wallis, and multivariable logistic regression analyses.
RESULTS: There were 142 patients with sTBI and 547 with non-sTBI injuries. Severe traumatic brain injury patients had lower initial hemoglobin (11.3 vs. 12.4, p < 0.001), greater initial international normalized ratio (1.4 vs. 1.1, p < 0.001), greater Injury Severity Score (25 vs. 5, p < 0.001), greater rates of ventilator (59% vs. 11%, p < 0.001) and intensive care unit (ICU) requirement (79% vs. 27%, p < 0.001), and more inpatient complications (18% vs. 3.3%, p < 0.001). Severe traumatic brain injury patients received more prehospital crystalloid (25% vs. 15%, p = 0.008), ≥1 crystalloid boluses (52% vs. 24%, p < 0.001), and blood transfusion (44% vs. 12%, p < 0.001) than non-sTBI patients. Among sTBI patients, receipt of ≥1 crystalloid bolus (n = 75) was associated with greater ICU need (92% vs. 64%, p < 0.001), longer median ICU (6 vs. 4 days, p = 0.027) and hospital stay (9 vs. 4 days, p < 0.001), and more in-hospital complications (31% vs. 7.5%, p = 0.003) than those who received <1 bolus (n = 67). These findings persisted after adjustment for Injury Severity Score (odds ratio, 3.4-4.4; all p < 0.010).
CONCLUSION: Pediatric trauma patients with sTBI received more crystalloid than those without sTBI despite having a greater international normalized ratio at presentation and more frequently requiring blood products. Excessive crystalloid may be associated with worsened outcomes, including in-hospital mortality, seen among pediatric sTBI patients who received ≥1 crystalloid bolus. Further attention to a crystalloid sparing, early transfusion approach to resuscitation of children with sTBI is needed.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- MacArthur TA, Vogel AM, Glasgow AE, et al. Crystalloid volume is associated with short-term morbidity in children with severe traumatic brain injury: An Eastern Association for the Surgery of Trauma multicenter trial post hoc analysis. J Trauma Acute Care Surg. 2023. PMID: 37072882. doi:10.1097/TA.0000000000004013
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。